Glutamine-Enriched Formula for Preterm Infant Brain Development
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Preterm and low birth weight infants require specialized nutritional compositions that meet their unique metabolic demands, as existing infant formulas and human milk do not fully support their rapid growth and brain development, leading to potential long-term cognitive and behavioral issues.
Innovation Solution
A glutamine-enriched nutritional composition, preferably administered in the first month after birth, with higher glutamine levels than standard formulas, in the form of free amino acids or dipeptides, to support energy supply and nucleotide synthesis, promoting improved brain development and growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If standard infant formulas or human milk are used for preterm infants, then basic nutritional needs are met, but the complete nutritional requirements for rapid growth and brain development are not satisfied
Solution Approach 1:
The patent modifies the nutritional composition by significantly increasing glutamine content to 12-80% of total protein (compared to typical 2-5% in standard formulas). This parameter change in amino acid composition directly addresses the insufficiency of standard formulas in meeting the elevated metabolic demands of preterm infants, particularly for brain development and growth.
2Reliability
If glutamine is supplemented in preterm infants, then brain development and cortical volume are improved, but the complexity of nutritional composition increases
Solution Approach 1:
The patent achieves improved brain development outcomes by modifying a single key parameter - the glutamine concentration in the nutritional formula. By focusing on this specific amino acid parameter rather than complex multi-component modifications, the solution simplifies the approach to enhancing nutritional completeness while maintaining formulation manageability.
Data Source
AI summary
The present invention relates to the use of nutritional compositions enriched in glutamine to improve structural and functional brain development in preterm and/or low birth weight infants.